Skip to content
PubMed This is a summary of 58 peer-reviewed journal articles Updated
Immunology · Complement Factor I Deficiency

Complement Factor I deficiency: A Patient Guide

At a Glance

Complete inherited Complement Factor I deficiency leaves a key immune pathway overactive, depletes protective C3, and raises the risk of rapidly progressing bacterial infections. Specialized vaccinations, daily preventive antibiotics, and lifelong specialist monitoring help reduce these risks.

Complement Factor I (CFI) deficiency is an ultrarare genetic condition that changes how your immune system protects you. This guide focuses on inherited complete (or near-complete) biallelic CFI deficiency, which requires different management than partial deficiencies, heterozygous carrier states, or acquired low Factor I levels.

To understand this condition, it helps to think of the complement system—a specific part of your immune system—as a powerful engine that is always idling, ready to accelerate at the first sign of an invader. In a typical immune system, Factor I helps act as a “brake,” regulating the system so it only amplifies when necessary and slows down once the threat is managed. In people with complete CFI deficiency, this regulatory brake is missing or functionally broken, causing the alternative complement pathway to become chronically overactive [1][2].

Because the system is constantly running, it profoundly depletes its own protective reserves—specifically a protein called C3. While your broader adaptive immune system (which makes antibodies) remains intact, the lack of C3 means your body cannot efficiently “tag” and destroy certain bacteria. This leaves you or your child highly vulnerable to “encapsulated” bacteria, which are responsible for severe, rapidly progressing infections like meningitis, pneumonia, and sepsis [1][3].

Beyond the risk of infection, the unchecked activity of the complement system can sometimes cause the body to inadvertently inflame its own tissues. While not inevitable for every patient, this can affect the kidneys through complement-mediated conditions like atypical Hemolytic Uremic Syndrome (aHUS) or C3 Glomerulopathy (C3G), and in some cases, it may affect the eyes by accelerating changes to the retina [4][5].

Managing this condition is a lifelong commitment to replacing the protection your body is missing. This is achieved through a “shield” of specialized, frequent vaccinations and daily preventive antibiotics that help stop bacteria before they can cause harm. Because the condition affects multiple systems, care requires a coordinated, individualized team of specialists—including immunologists, nephrologists, and primary care providers—who monitor your health through regular labs and exams [6][7].

While the diagnosis of an ultrarare disease is life-changing, it is also a powerful tool. By understanding the biology of the deficiency, you can move from a place of uncertainty to one of active protection. With a dedicated medical team and a consistent preventive plan, the focus shifts from managing crises to maintaining a healthy, active life [6][3].

Common questions in this guide

What happens in complete Complement Factor I deficiency?
Factor I normally acts as a brake on part of the immune system called the complement system. In complete or near-complete deficiency, that pathway can stay overactive, use up C3, and reduce the body's ability to defend against certain bacteria.
Why are infections such a serious concern with CFI deficiency?
A lack of C3 makes it harder for the immune system to tag and clear certain bacteria with protective outer coatings. These infections can progress rapidly and include meningitis, pneumonia, or sepsis, so families need a clear plan for fever.
How is complete CFI deficiency diagnosed?
Doctors may combine genetic testing with functional tests of the complement system to confirm complete or near-complete deficiency. This helps distinguish it from partial deficiency, carrier status, or an acquired low Factor I level.
How can someone with CFI deficiency prevent serious infections?
Protection typically includes specialized, frequent vaccinations and daily preventive antibiotics. An immunologist or primary care clinician can create an individualized schedule and explain what to do for fever, missed medication, or travel.
Can Complement Factor I deficiency affect the kidneys or eyes?
Yes. Unchecked complement activity may contribute to kidney conditions such as atypical hemolytic uremic syndrome or C3 glomerulopathy, and it may accelerate retinal changes in some people. Regular kidney and eye monitoring can help the care team detect complications.
Which specialists should manage CFI deficiency?
Care is usually coordinated by an immunologist with a primary care clinician and, when needed, nephrology and ophthalmology specialists. Regular laboratory tests and medical examinations help the team monitor infection risk and possible kidney or eye complications.
What should I do if someone with CFI deficiency develops a fever?
A person with complete CFI deficiency should have a written fever and after-hours plan from their medical team because bacterial infections can progress quickly. Ask which number to call, when to seek emergency care, and what to do while traveling, and follow that plan rather than waiting for routine office hours.

Get notified when new evidence is published on Immunodeficiency with factor I anomaly.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (7)
  1. 1

    Complete Complement Factor I (CFI) deficiency: a systematic review of forty-nine patients including three novel cases.

    Rajabi E, Kheirabadi MC, Olyaei NA, et al.

    BMC immunology 2025; (26(1)):54 doi:10.1186/s12865-025-00739-y.

    PMID: 40713518
  2. 2

    Complement factor I: Regulatory nexus, driver of immunopathology, and therapeutic.

    Hallam TM, Sharp SJ, Andreadi A, Kavanagh D

    Immunobiology 2023; (228(5)):152410 doi:10.1016/j.imbio.2023.152410.

    PMID: 37478687
  3. 3

    Early Versus Late Diagnosis of Complement Factor I Deficiency: Clinical Consequences Illustrated in Two Families with Novel Homozygous CFI Mutations.

    Franco-Jarava C, Álvarez de la Campa E, Solanich X, et al.

    Journal of clinical immunology 2017; (37(8)):781-789 doi:10.1007/s10875-017-0447-x.

    PMID: 28942469
  4. 4

    C3 glomerulonephritis and thrombotic microangiopathy of renal allograft after pulmonary infection in a male with concomitant two complement factor I gene variations: a case report.

    Wen J, Wang W, Xu F, et al.

    BMC nephrology 2018; (19(1)):148 doi:10.1186/s12882-018-0952-z.

    PMID: 29940891
  5. 5

    Rare complement factor I variants associated with reduced macular thickness and age-related macular degeneration in the UK Biobank.

    Tzoumas N, Kavanagh D, Cordell HJ, et al.

    Human molecular genetics 2022; (31(16)):2678-2692 doi:10.1093/hmg/ddac060.

    PMID: 35285476
  6. 6

    Inherited Classical and Alternative Pathway Complement Deficiencies in Children: A Single Center Experience.

    Genel F, Erdem SB, Gülez N, et al.

    Iranian journal of immunology : IJI 2018; (15(4)):309-320 doi:10.22034/IJI.2018.39400.

    PMID: 30593745
  7. 7

    Clinical laboratory standard capillary protein electrophoresis alerted of a low C3 state and lead to the identification of a Factor I deficiency due to a novel homozygous mutation.

    Franco-Jarava C, Colobran R, Mestre-Torres J, et al.

    Immunology letters 2016; (174()):19-22.

    PMID: 27091480

This page provides general information about complete inherited Complement Factor I deficiency and does not constitute medical advice. Your immunologist and other specialists should guide vaccination, antibiotic, laboratory monitoring, and urgent-fever plans.